Barrington Research Maintains Outperform on Concentrix, Maintains $121 Price Target
Portfolio Pulse from Benzinga Newsdesk
Barrington Research analyst Vincent Colicchio has maintained an Outperform rating on Concentrix (NASDAQ:CNXC) and kept the price target at $121.
March 20, 2024 | 2:34 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Barrington Research maintains an Outperform rating on Concentrix with a $121 price target.
The reaffirmation of an Outperform rating and a $121 price target by Barrington Research suggests a strong confidence in Concentrix's future performance. This positive outlook from a reputable analyst could lead to increased investor confidence in CNXC, potentially driving its stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100